<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang C</submitter><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>15668-71</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5039010</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>137(50)</volume><pubmed_abstract>An enantioselective, intermolecular dehydrogenative Heck arylation of trisubstituted alkenes to construct remote quaternary stereocenters has been developed. Using a new chiral pyridine oxazoline ligand, good to high enantioselectivity is achieved for various combinations of indole derivatives and trisubstituted alkenes. However, some combinations of substrates led to lower enantioselectivity, which provided the impetus to use structure enantioselectivity correlations to design a better performing ligand.</pubmed_abstract><journal>Journal of the American Chemical Society</journal><pubmed_title>Enantioselective Dehydrogenative Heck Arylations of Trisubstituted Alkenes with Indoles to Construct Quaternary Stereocenters.</pubmed_title><pmcid>PMC5039010</pmcid><funding_grant_id>R01GM063540</funding_grant_id><funding_grant_id>R01 GM063540</funding_grant_id><pubmed_authors>Crawford JM</pubmed_authors><pubmed_authors>Santiago CB</pubmed_authors><pubmed_authors>Sigman MS</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Enantioselective Dehydrogenative Heck Arylations of Trisubstituted Alkenes with Indoles to Construct Quaternary Stereocenters.</name><description>An enantioselective, intermolecular dehydrogenative Heck arylation of trisubstituted alkenes to construct remote quaternary stereocenters has been developed. Using a new chiral pyridine oxazoline ligand, good to high enantioselectivity is achieved for various combinations of indole derivatives and trisubstituted alkenes. However, some combinations of substrates led to lower enantioselectivity, which provided the impetus to use structure enantioselectivity correlations to design a better performing ligand.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Dec</publication><modification>2024-11-14T16:08:02.813Z</modification><creation>2019-03-27T02:25:14Z</creation></dates><accession>S-EPMC5039010</accession><cross_references><pubmed>26624236</pubmed><doi>10.1021/jacs.5b11335</doi></cross_references></HashMap>